Gordon Francis

Multiple sclerosis patients—benefit-risk preferences: Serious adverse event risks versus treatment efficacy

F. Reed Johnson, David W. Miller, G. Houtven, 2009, Journal of Neurology.

The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability

Gary R Cutter, Paul M Matthews, Peter Feys, 2017, Multiple sclerosis.

Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis

Ludwig Kappos, Till Sprenger, Frederik Barkhof, 2015, Neurology.

The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis

Ilse Lamers, Peter Feys, Lynn D. Hudson, 2017, Multiple sclerosis.

Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis

Volker Brinkmann, Pascale Burtin, G. Francis, 2010, Nature Reviews Drug Discovery.